2022 Shorebirds Competition Summary and Results
Shorebirds Competition 2022 results.
Showing 841 - 860 of 1014 results
Development of radioisotopes
Research and development activity explores new, boutique radioisotopes, including positron, gamma and beta/gamma emitter. The aim is to provide material for the next generation of diagnostic and therapeutic radiopharmaceuticals
Board member
Dr Storr has worked for over 40 years in nuclear science and technology in a range of positions spanning operations, research and executive management.
Principal Scientist – X-ray Fluorescence Microscopy
Principal Scientist – X-ray Fluorescence Microscopy
Instrument Scientist
Role at ANSTO
Dr Richard Mole is an instrument scientist co-responsible for the cold-neutron time-of-flight spectrometer PELICAN.
Critical minerals projects funded under Australian Research Centre Projects Program
ANSTO is contributing to key critical minerals projects funded by the Federal Government.
Cross collaboration on highly competitive funding for projects and facilities
Building knowledge of changes in uranium chemistry
A new systematic investigation of the origins of atomic structural distortions in compounds containing uranium has relevance for spent nuclear fuel .
Silicon irradiation
ANSTO is one of the world's leading providers of irradiation services for silicon ingots, which are used by the multimillion dollar electronics industry across Europe and Asia. Each year, ANSTO irradiates more than 50 tonnes of silicon.
Principal Research Scientist
Role at ANSTO
UM2022 Speakers
Radiotracer studies
The use of radioisotopes, radiolabeled molecules and radioactive particles in conjunction with a range of quantitative imaging spectroscopy and radiation counting methods.
Research Leader, ANSTO and CEO of GaiaPOD. Particle physicist. Entrepreneur. Inventor. Science realist and Superstar of STEM.
Dr Safavi-Naeini is the Acting Leader of the Centre for Accelerator Science. She is a particle physicist and previously had a role as a research leader at the Human Health group.
Scientist - MEX
Role at ANSTO
ANSTO is the new production partner of OncoBeta® GmbH in Australia
Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia
OPAL reactor back online after planned long shutdown
ANSTO’s OPAL multi-purpose research reactor at Lucas Heights has officially returned to power and recommenced operations, following a months-long planned shutdown to carry out essential maintenance and upgrades.
Small Modular Reactors: An overview
ANSTO - National Science Week
Principal RF Engineer